TRDA
Entrada Therapeutics, Inc. · Healthcare
President and CEO Dipal Doshi sold $28K of Entrada Therapeutics, Inc.
Sold$27,826
$13.91Price
2,000Shares
−1%Stake
What TRDA did after the filing
- The stock from Wed, Nov 30 close, $14.97
- −8.4%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Jan 13 close.
Traded Mon, Nov 28. Filed Wed, Nov 30, 11:31 AM ET, during the session. Returns use the Nov 30 close and the Jan 13 close. Not investment advice.